Uncompetitive inhibition is important in the study of enzyme chemistry because it describes a specific method of reducing the activity of enzymes in a catalytic reaction. This type of inhibition involves an inhibitor compound that connects with the enzyme-substrate complex to prevent the creation of the product. Uncompetitive inhibition has been found to be useful in the field of medicine and other scientific fields.
The significance of uncompetitive inhibition has been highlighted in biochemistry and pharmacology. One example of uncompetitive inhibition is the use of lithium to prevent inositol monophosphatase that causes manic-depressive psychosis.
Uncompetitive inhibition belongs to a class of compounds called reversible inhibitors, which can be removed from a reaction to reverse its effects. Although both are reversible, uncompetitive inhibition is different from competitive inhibition, which involves the binding of an inhibitor to the enzyme so that it disrupts the possible connection of the enzyme to the substrate. In this scenario, the inhibitor attempts to mimic the structure of the substrate, thereby preventing the latter to connect with the enzyme. In some cases, competitive inhibitors may alter the structure of the enzyme itself so that the substrate becomes incompatible.
In contrast, uncompetitive inhibition does not prevent the substrate from binding with the enzyme. This type of inhibitor allows the enzyme and substrate to form a complex, upon which the inhibitor will bind. As a result, the altered complex cannot release the desired products.